title: Long-term outcome in kidney recipients from donors treated with hydroxyethylstarch 130/0.4 and hydroxyethylstarch 200/0.6.
authors.affiliation: Marseille, France.
authors.forename: V
authors.initials: V
authors.lastname: Blasco
authors.affiliation: Marseille, France.
authors.forename: J C
authors.initials: JC
authors.lastname: Colavolpe
authors.affiliation: Marseille, France.
authors.forename: F
authors.initials: F
authors.lastname: Antonini
authors.affiliation: Marseille, France.
authors.forename: L
authors.initials: L
authors.lastname: Zieleskiewicz
authors.affiliation: Marseille, France.
authors.forename: C
authors.initials: C
authors.lastname: Nafati
authors.affiliation: Marseille, France.
authors.forename: J
authors.initials: J
authors.lastname: Albanèse
authors.affiliation: Marseille, France marc.leone@ap-hm.fr.
authors.forename: M
authors.initials: M
authors.lastname: Leone
mesh_terms: D001926:Brain Death; D003404:Creatinine / Q000097:blood; D005500:Follow-Up Studies; D006084:Graft Rejection; D006801:Humans; D006895:Hydroxyethyl Starch Derivatives / Q000031:analogs & derivatives* / Q000627:therapeutic use; D016030:Kidney Transplantation; D012189:Retrospective Studies; D014019:Tissue Donors; D016896:Treatment Outcome
chemical_list: C485123:HES 130-0.4; D006895:Hydroxyethyl Starch Derivatives; C517718:hydroxyethylstarch 200; D003404:Creatinine